Acknowledgment Stem Cell

Dr Friedberg is supported in part by a grant from the National Cancer Institute (CA102216).

14. Misgeld E, Germing U, Aul C, et al.: Secondary myelodys-plastic syndrome after fludarabine therapy of a low-grade non-Hodgkin's lymphoma. Leuk Res 25:95-98, 2001.

15. Pedersen-Bjergaard J, Andersen MK, Christiansen DH: Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation. Blood 95: 3273-3279, 2000.

16. Friedberg JW, Fisher RI: Iodine-131 tositumomab (Bexxar(R)): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphoma. Expert Rev Anticancer Ther 4:18-26, 2004.

17. Cheson BD: Radioimmunotherapy of non-Hodgkin lymphomas. Blood 101:391-398, 2003.

18. Bennett JM, Zelenetz AD, Press OW, et al.: Incidence of myelodysplastic syndromes (tMDS) and acute myeloid leukemia (tAML) in patients with low-grade non-Hodgkin's lymphoma (LG-NHL) treated with Bexxarâ„¢. Blood 98, 2001.

19. Armitage JO, Carbone PP, Connors JM, et al.: Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients. J Clin Oncol 21:897-906, 2003.

20. Akpek G, Ambinder RF, Piantadosi S, et al.: Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol 19:4314-4321, 2001.

21. Friedberg JW, Neuberg D, Stone RM, et al.: Outcome in patients with myelodysplastic syndrome after autolo-gous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 17:3128-3135, 1999.

22. Friedberg J, Neuberg D, Freedman AS: Myelodysplasia after autotransplantation. J Clin Oncol 18:3446-3447, 2000.

23. Milligan DW, Ruiz De Elvira MC, Kolb HJ, et al.: Secondary leukaemia and myelodysplasia after auto-grafting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol 106:1020-1026, 1999.

24. Metayer C, Curtis RE, Vose J, et al.: Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood 101:2015-2023, 2003.

25. Govindarajan R, Jagannath S, Flick JT, et al.: Preceding standard therapy is the likely cause of MDS after auto-transplants for multiple myeloma. Br J Haematol 95:349-353, 1996.

26. Roman-Unfer S, Bitran JD, Hanauer S, et al.: Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. Bone Marrow Transplant 16:163-168, 1995.

27. Laughlin MJ, McGaughey DS, Crews JR, et al.: Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. J Clin Oncol 16:1008-1012, 1998.

28. Kollmannsberger C, Beyer J, Droz JP, et al.: Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors. J Clin Oncol 16:3386-3391, 1998.

29. Taylor PR, Jackson GH, Lennard AL, et al.: Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow. Leukemia 11:1650-1653, 1997.

30. Andre M, Henry-Amar M, Blaise D, et al.: Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. Blood 92:1933-1940, 1998.

31. Harrison CN, Gregory W, Hudson GV, et al.: High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. Br J Cancer 81:476-483, 1999.

32. Pedersen-Bjergaard J, Pedersen M, Myhre J, et al.: High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. Leukemia 11:1654-1660, 1997.

33. Josting A, Wiedenmann S, Franklin J, et al.: Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3440-3446, 2003.

34. Micallef IN, Lillington DM, Apostolidis J, et al.: Therapy-related myelodysplasia and secondary acute myeloge-nous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol 18:947, 2000.

35. Bhatia S, Ramsay NK, Steinbuch M, et al.: Malignant neoplasms following bone marrow transplantation. Blood 87:3633-3639, 1996.

36. Darrington DL, Vose JM, Anderson JR, et al.: Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following highdose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527-2534, 1994.

37. Hosing C, Munsell M, Yazji S, et al.: Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Ann Oncol 13:450-459, 2002.

38. Wheeler C, Khurshid A, Ibrahim J, et al.: Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine and etoposide (CBV). Leuk Lymphoma 40:499-509, 2001.

39. Sureda A, Arranz R, Iriondo A, et al.: Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol 19: 1395-1404, 2001.

40. Friedberg JW: Myelodysplasia after autologous stem cell transplantation. In: Atkinson K, Champlin R, Ritz J, et al. (eds.) Clinical Bone Marrow and Stem Cell Transplantation. Boston: Cambridge University Press, 2004.

41. Yahalom J, Petrek JA, Biddinger PW, et al.: Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. J Clin Oncol 10:1674-1681, 1992.

42. Diller L, Medeiros Nancarrow C, Shaffer K, et al.: Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. J Clin Oncol 20:2085-2091, 2002.

43. Liberman L: Breast cancer screening with MRI-what are the data for patients at high risk? N Engl J Med 351: 497-500, 2004.

44. Kriege M, Brekelmans CT, Boetes C, et al.: Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437, 2004.

45. Wu D, Gambhir SS: Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives. Clin Breast Cancer 4(suppl 1):S55-S63, 2003.

46. Vogel VG, Costantino JP, Wickerham DL, et al.: The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial. Clin Breast Cancer 3:153-159, 2002.

47. Horwich A, Swerdlow AJ: Second primary breast cancer after Hodgkin's disease. Br J Cancer 90:294-298, 2004.

48. MacRedmond R, Logan PM, Lee M, et al.: Screening for lung cancer using low dose CT scanning. Thorax 59: 237-241, 2004.

49. Gilliland DG, Gribben JG: Evaluation of the risk of therapy-related MDS/AML after autologous stem cell transplantation. Biol Blood Marrow Transplant 8:9-16, 2002.

50. Berglund A, Enblad G, Carlson K, et al.: Long-term follow-up of autologous stem-cell transplantation for follic-ular and transformed follicular lymphoma. Eur J Haematol 65:17-22, 2000.

51. Mounier N, Gisselbrecht C: Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 9:S15-S21, 1998.

52. Armitage JO: Myelodysplasia and acute leukemia after autologous bone marrow transplantation. J Clin Oncol 18:945, 2000.

53. Foss Abrahamsen A, Andersen A, Nome O, et al.: Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time. Ann Oncol 13:1786-1791, 2002.

This page intentionally left blank

Chapter 79

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment